Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-06-17FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
FDA approved a supplemental application for buprenorphine hydrochloride under an ANDA, indicating an additional approved formulation or use.
-
FDA approval · 2022-06-13FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)
The FDA approved a supplemental application for buprenorphine hydrochloride from Advagen Pharma Ltd, enabling an additional generic version …
-
FDA approval · 2022-06-13FDA Approved: BUPRENORPHINE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for buprenorphine from Rhodes Pharmaceuticals L.P., indicating an update to the product's regulatory…
-
FDA approval · 2022-05-17FDA Approved: BUPRENORPHINE TRANSDERMAL SYSTEM — Original Application (Alvogen Inc.)
FDA approved an original ANDA for buprenorphine transdermal system (generic buprenorphine) for chronic pain management.
-
FDA approval · 2022-05-03FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
The FDA approved a supplemental application for buprenorphine hydrochloride submitted by PAI Holdings/PAI Pharma, authorizing changes to the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-05-03FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)
FDA approved a supplemental application for buprenorphine hydrochloride filed by Advagen Pharma Ltd, indicating an approval related to an ex…
-
FDA approval · 2022-05-03FDA Approved: BUPRENORPHINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA granted supplemental approval for buprenorphine from Sun Pharmaceutical Industries, approving changes to the approved product pursua…
-
FDA approval · 2022-05-03FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for buprenorphine from Actavis Pharma, Inc. under the ANDA, indicating changes to labeling or in…
-
FDA approval · 2022-04-21FDA Approved: DSUVIA — Supplemental Application (AcelRx Pharmaceuticals, Inc.)
The FDA approved a supplemental application for DSUVIA (sufentanil) from AcelRx Pharmaceuticals, Inc.
-
FDA approval · 2022-03-22FDA Approved: IBUPROFEN — Supplemental Application (Aurohealth LLC)
The FDA approved a supplemental application for ibuprofen filed by Aurohealth LLC, authorizing the generic ibuprofen product.
-
FDA approval · 2022-03-16FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for methadone hydrochloride from SpecGx LLC, updating an existing ANDA product.
-
FDA approval · 2022-03-09FDA Approved: CELECOXIB — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Celecoxib from Micro Labs Limited under an ANDA.
-
FDA approval · 2022-01-10FDA Approved: ADVIL PM- DIPHENHYDRAMINE CITRATE AND IBUPROFEN TABLET, COATED — Supplemental Application (Lil Drug Store Products, Inc)
FDA approved a supplemental application for Advil PM, a coated tablet containing ibuprofen and diphenhydramine citrate, with Lil Drug Store …
-
FDA approval · 2021-12-30FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Original Application (Cranbury Pharmaceuticals, LLC)
The FDA approved a generic hydrocodone bitartrate and acetaminophen product (hydrocodone/acetaminophen) from Cranbury Pharmaceuticals, LLC u…
-
FDA approval · 2021-12-15FDA Approved: MORPHINE SULFATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Morphine Sulfate from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2021-11-24FDA Approved: BUPRENORPHINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for buprenorphine from Hikma Pharmaceuticals USA Inc., granting approval for this generic produc…
-
FDA approval · 2021-09-23FDA Approved: BUPRENORPHINE — Original Application (INGENUS PHARMACEUTICALS, LLC)
FDA approved a generic buprenorphine product from Ingenus Pharmaceuticals under the original ANDA application (ANDA210272).
-
FDA approval · 2021-09-10FDA Approved: TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Trigen Laboratories, LLC)
FDA approved a supplemental application for tramadol hydrochloride extended-release sponsored by Trigen Laboratories, LLC.
-
FDA approval · 2021-09-10FDA Approved: TRAMADOL HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for tramadol hydrochloride from Sun Pharmaceutical Industries, Inc., enabling continued marketin…
-
FDA approval · 2021-06-25FDA Approved: SUFENTANIL CITRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for sufentanil citrate from Hospira, Inc., under ANDA074534.
-
FDA approval · 2021-06-16FDA Approved: CHILDRENS IBUPROFEN — Supplemental Application (Better Living Brands, LLC)
The FDA approved a supplemental application for Children's Ibuprofen (ibuprofen) from Better Living Brands, LLC, indicating changes to the a…
-
FDA approval · 2021-06-02FDA Approved: METHADOSE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for METHADOSE (methadone hydrochloride) submitted by SpecGx LLC.
-
FDA approval · 2021-06-02FDA Approved: MORPHINE SULFATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Morphine Sulfate by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2021-06-02FDA Approved: DISKETS — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for DISKETS (methadone hydrochloride) filed by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2021-06-02FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for methadone hydrochloride from Mylan Institutional LLC, indicating an update to the product's labe…